The Mole Clinic Ltd.

The Mole Clinic Ltd. is a UK-based healthcare provider specializing in skin cancer screening and mole removal services, focusing on comprehensive skin health solutions for individuals aged 18 and over. Founded in 2003 and headquartered in London, The Mole Clinic Ltd. provides essential skin cancer detection and treatment services.

Notably, the company underwent a significant change in ownership when, in August 2024, Palaitine acquired a majority stake from Sk:n Ltd. , Connection Capital, and TriSpan. The founder, Iain Mack, has experience in the healthcare sector, but further details on his prior ventures are not available. The Mole Clinic specializes in skin cancer screening and mole removal services targeting individuals aged 18 and over.

It offers a range of services including single mole checks, full body skin examinations, and full body mole mapping, all performed by qualified skin specialists. Additionally, the clinic provides mole surveillance imaging and the removal and biopsy of suspicious moles, addressing the rising issue of skin cancer prevalence, especially in those with sunburn histories. The clinic serves multiple UK locations including London, Manchester, Bristol, Brighton, Edinburgh, and Glasgow. In 2022, The Mole Clinic reported revenues of GBP 5,020,213 and an EBITDA of GBP 1,777,156.

The clinic operates on a fee-for-service model, with consultation fees set at GBP 195 and skin cancer screenings starting at GBP 60. Other charges apply for mole removals and biopsies, ensuring timely service and prompt results, which are typically available within 1 to 3 days. Following the acquisition in August 2024, The Mole Clinic Ltd. aims to expand its network of clinics throughout the UK.

The recent funding will facilitate this expansion, allowing the company to enhance its service offerings and reach more clients. Specific regions targeted for growth have not been detailed, but the focus remains on increasing accessibility to its services across various locales.